PURPOSE: To present safety and efficacy results obtained in treatment of a cohort of
patients with unresectable hepatocellular carcinoma (HCC) with use of 90 Y microspheres (…

PURPOSE: F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) imaging is
now considered the most accurate clinical staging study for non–small-cell lung cancer (…

The rapid evolution and increasing complexity of liver-directed therapies has forced the
medical community to further advance its understanding of hepatic arterial anatomy. The …

Purpose: To prospectively evaluate the safety, efficacy, and survival of patients with
chemorefractory liver metastases who have been treated with yttrium 90 ( 90 Y) glass microspheres. …

PURPOSE: The purpose of this phase II study was to determine the safety and efficacy of
TheraSphere treatment ( 90 Y microspheres) in patients with liver-dominant colorectal …

Purpose: We aim to compare the metabolic activity by F-18 fluorodeoxyglucose (FDG) uptake
across the various histologic subtypes of non-Hodgkin lymphoma (NHL) in a single center, …

Purpose: To compare the planning target volume (PTV) definitions for computed
tomography (CT) vs. positron emission tomography (PET) in non–small-cell lung cancer (NSCLC). …

SPECT and PET were measured and compared. Both SPECT and PET studies were performed
in two groups of 18 patients each, with Group I using HE SPECT and Group II using UH …

Fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) detects
recurrence of papillary thyroid carcinoma (PTC) in thyroidectomized patients with elevated …

The aim of this study was to identify useful patterns of abnormal fluorine-18 fluorodeoxyglucose
(FDG) uptake by different types of non-small cell (NSC) lung cancer and to assess their …